NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression

BACKGROUND: Easily accessible biomarkers enabling the identification of those patients with multiple sclerosis (MS) who will accumulate irreversible disability in the long term are essential to guide early therapeutic decisions. We here examine the utility of serum neurofilament light chain (sNfL) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Uphaus, Timo, Steffen, Falk, Muthuraman, Muthuraman, Ripfel, Nina, Fleischer, Vinzenz, Groppa, Sergiu, Ruck, Tobias, Meuth, Sven G., Pul, Refik, Kleinschnitz, Christoph, Ellwardt, Erik, Loos, Julia, Engel, Sinah, Zipp, Frauke, Bittner, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479646/
https://www.ncbi.nlm.nih.gov/pubmed/34571362
http://dx.doi.org/10.1016/j.ebiom.2021.103590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479646/
https://www.ncbi.nlm.nih.gov/pubmed/34571362
http://dx.doi.org/10.1016/j.ebiom.2021.103590

Ejemplares similares